Kellokumpu-Lehtinen, P., Bergh, J., Salminen, E., Wiklund, T., Lehtinen, S., Aronen, P., & Sintonen, H. (2007). Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy – results from a ra. Acta Oncologica, 46(2), 146–152. https://doi.org/10.1080/02841860600965012